Document Detail

Mutations and polymorphic BRCA variants transmission in breast cancer familial members.
MedLine Citation:
PMID:  20352487     Owner:  NLM     Status:  In-Data-Review    
We previously showed that about 80% of breast cancer patients at high risk to carry mutation in BRCA genes presented at least one polymorphism in these genes which resulted potentially harmful by in silico analysis. In the present paper, the genealogic transmission of those polymorphic coding and noncoding variants of BRCA genes in family's members has been investigated. Thirty families, enrolled within the Genetic Counselling Program of our Institute, with probands and at least one-first degree relative (n = 67 family members) available, have been studied for both BRCA1 and BRCA2 pathological mutation and polymorphic variants' transmission. Ten and 6 probands carried Mendelian transmitted mutations in BRCA1 and BRCA2, respectively. Polymorphic coding and noncoding variants were transmitted in each family's relatives with a frequency ranging from 42 to 100%, with similar rate for each SNP in mutated and nonmutated families with the only exception of BRCA1 K1183R significantly more frequent in mutated families (P = 0.004); conversely, this SNP and BRCA2 N372H, were more frequently present in breast cancer relatives belonging to families in which pathological BRCA mutations were not present. Furthermore, specific haplotypes were transmitted in all relatives as BRCA1 871Leu-1038Gly, present in both BRCA mutated and nonmutated families, while BRCA2 289His-991Asp-IVS14+53 C>T present only in BRCAX families suggesting the harmful role of these SNPs. In conclusion, analysis of SNPs maps and modality of their transmission could identify further susceptibility markers and provide a basis for a better DNA-based cancer classification.
Brunella Pilato; Marianna Martinucci; Katia Danza; Rosamaria Pinto; Daniela Petriella; Rosanna Lacalamita; Michele Bruno; Rossana Lambo; Cosimo D'Amico; Angelo Paradiso; Stefania Tommasi
Related Documents :
17279547 - Classification of missense variants of unknown significance in brca1 based on clinical ...
18646247 - The phases of disclosing brca1/2 genetic information to offspring.
9450187 - Could the 185delag brca1 mutation be an ancient jewish mutation?
18573707 - Birt-hogg-dubé (bhd) syndrome: report of two novel germline mutations in the folliculi...
23006617 - A novel exonic ghr splicing mutation (c.784g > c) in a patient with classical growth ho...
21086177 - The csn1s1 n and f alleles identified by pcr-sscp and their associations with milk yie...
Publication Detail:
Type:  Journal Article     Date:  2010-03-30
Journal Detail:
Title:  Breast cancer research and treatment     Volume:  125     ISSN:  1573-7217     ISO Abbreviation:  Breast Cancer Res. Treat.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-20     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8111104     Medline TA:  Breast Cancer Res Treat     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  651-7     Citation Subset:  IM    
Clinical Experimental Oncology Laboratory, National Cancer Institute, "Giovanni Paolo II"- v., Hahneman 10, 70126, Bari, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: a systematic rev...
Next Document:  Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative ...